Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of erythropoietin in Friedreich's ataxia
2005-005938-12Phase 2Completed
- Sponsor
- Dr. Sylvia Boesch
- Start
- Apr 2006
- Modality
- Erythropoietins → Hormones & Growth Factors → Recombinant Proteins and Enzymes, Interleukins → Cytokines & Interferons → Recombinant Proteins and Enzymes, Colony Stimulating Factors → Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of epoetin beta in Friedreich ataxia (FA), sponsored by Dr. Sylvia Boesch. Started Apr 2006; status: completed.
02
Drugs
epoetin beta
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2005-005938-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005938-12.